Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

RNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by the U.S.

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

U.S. equities rose at midday on optimism the new tariffs threatened by President Trump won't be as severe as initially ...

Yesterday the World Health Organization (WHO) said Tanzania has 1 confirmed case of Marburg and 25 suspected cases all from ...